It might sound strange, but the Covid-19 pandemic could potentially help save people from dying of cancer and hepatitis.
Thomas Shinecker, CEO of Roche Diagnostics, already sees signs that healthcare authorities around the world will invest more in early diagnostics for a number of diseases following the Covid-19 pandemic.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Hearing firms urge FDA to increase OTC safety requirements
A number of the world’s biggest hearing aid manufacturers have come together to encourage the US health authority to tighten the safety requirements for OTC hearing aids, which will hit the shelves in the US sometime this year.
Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
Coloplast initiates trial of ostomy leakage product
The medtech company will being clinically testing its ostomy add-on product, Heylo, in January.
Top news from MedWatch this week
Miss anything?
Danish bank cuts Genmab price target, retains "buy" recommendation
Jyske Bank has adjusted its valuation of Genmab’s share price target to DKK 2850 (USD 434.4). Investors should continue to buy, the Danish bank says.
Senior Manager, Accounting Operations 
Senior Key Account Manager 
Commercial Excellence Lead 
Senior Manager/Associate Director Regulatory Affairs 
NORDIC Medical Sales Director 
QA Specialist, GMP QA 
GxP QA Compliance Manager for Quality Assurance 
Chemists are wanted for ALK's internal Aircraft Corps 
Principal Scientist 
QA Specialist 
Clinical Research Associate 
Head of Biology Group Human Milk Oligosaccharides & Early Life Nutrition, DSM/Glycom 
Director Medical Science